文献速递头颈部肿瘤放疗放疗物理与技术

舌外伸放疗技术辅助下咽缩肌保护性挽救立体定向体部放疗治疗头颈癌根治性放疗后野内复发:舌外伸放疗指南

Pharyngeal Constrictor-Sparing Salvage Stereotactic Body Radiation Therapy With Tongue-Out for In-Field Recurrence After Definitive Radiation Therapy for Head and Neck Cancer: Guide to Tongue-Out Radiation Therapy.
PubMed 文献 · Pract Radiat Oncol · 2024-07-22

本报告描述一例4年前因局部晚期喉癌接受根治性放化疗(70 Gy联合每周顺铂)后出现悬雍垂局部复发的患者,采用本院舌外伸放疗技术(TORT)实施咽缩肌保护性挽救立体定向体部放疗。TORT通过30 cc药杯优化可重复的舌外伸位置、舌外伸状态下塑形热塑膜并在CT模拟、锥形束CT采集和治疗中实时视觉监测舌位来实施。与无TORT相比,TORT使内侧上咽缩肌与悬雍垂大体肿瘤靶区最短距离增加13 mm,上咽缩肌平均剂量从20.5 Gy降至12.7 Gy。

要点

  • TORT使内侧上咽缩肌与悬雍垂大体肿瘤靶区最短距离增加13 mm。
  • 上咽缩肌平均剂量从无TORT的20.5 Gy降至有TORT的12.7 Gy。
  • 有TORT时上咽缩肌V60%Rx、V80%Rx、V100%Rx分别为0.7 cc、0.19 cc、0.04 cc,均低于无TORT时的4.8 cc、2.9 cc、1.6 cc。

核心结论

  • 在挽救性再照射中应用TORT可避免上咽缩肌接受高剂量照射并避免分次内吞咽相关的悬雍垂大体肿瘤靶区地理性脱靶。
  • 患者成功完成TORT辅助挽救性立体定向体部放疗,无吞咽困难或黏膜炎,治疗后12个月维持完全缓解。

研究设计与样本

  • 本报告详述一例4年前因局部晚期喉癌接受根治性放化疗(70 Gy联合每周顺铂)后悬雍垂局部复发患者,采用本院TORT技术实施咽缩肌保护性挽救立体定向体部放疗(32.5 Gy分5次)。

主要发现

  • 与无TORT相比,TORT使内侧上咽缩肌与悬雍垂大体肿瘤靶区最短距离增加13 mm。
  • 上咽缩肌平均剂量从无TORT的20.5 Gy降至有TORT的12.7 Gy。
  • 有TORT时上咽缩肌V60%Rx、V80%Rx、V100%Rx分别为0.7 cc、0.19 cc、0.04 cc,无TORT时分别为4.8 cc、2.9 cc、1.6 cc。
  • 内侧上咽缩肌最大剂量无TORT为34.6 Gy,有TORT为22.7 Gy。

关键数值与推荐

  • TORT包括使用30 cc药杯优化患者可重复的舌外伸位置、舌外伸状态下塑形热塑膜,并在CT模拟扫描、锥形束CT采集和治疗中实时视觉监测舌位。
  • 在容积旋转调强放疗的弧间可给予患者舌放松和吞咽唾液的时间。

临床怎么用

  • 本研究中心的做法是采用TORT技术实施咽缩肌保护性挽救立体定向体部放疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This report details a pharyngeal constrictor muscle (PCM)-sparing stereotactic body radiation therapy (SBRT) using our institutional technique of "tongue-out" radiation therapy (TORT) for treating a local recurrent cancer in the uvula (GTVuvula) in a patient with history of a definitive chemotherapy with radiation therapy (70 Gy with weekly cisplatin) for a locally advanced laryngeal cancer 4 years ago. TORT includes optimizing the patients' reproducible tongue-out position using readily available medicine cup (30 cc) followed by sculping the thermoplastic mask with tongue-out, and real-time visual monitoring of the tongue position during the computed tomography simulation scan, cone beam computed tomography acquisition, and treatment. Between arcs during volumetric modulated arc therapy, time for tongue relaxation and saliva swallowing can be given to the patient. Without TORT, the patient's GTVuvula abutted the medial aspect of superior PCM (medial-sPCM) and a substantial volume of the previously irradiated superior PCM (sPCM) would have received high radiation dose from this salvage SBRT (32.5 Gy in 5 fractions). Comparing without TORT, the shortest distance between medial-sPCM-to-GTVuvula was increased by 13 mm with TORT, which reduced radiation dose to sPCM in the salvage SBRT plan. The mean dose to sPCM was decreased from 20.5 Gy without TORT to 12.7 Gy with TORT. With TORT, minimal sPCM volumes fell within higher isodose line: volume receiving ≥ 60% prescription dose (V60%Rx), V80%Rx, and V100%Rx to sPCM was, 4.8 versus 0.7 cc (without vs with TORT, respectively), 2.9 versus 0.19 cc, and 1.6 versus 0.04 cc, respectively. Maximum dose (Dmax) to medial-sPCM was 34.6 Gy without TORT versus 22.7 Gy with TORT. These high doses to the sPCM and intrafractional swallowing-related geographic misses of GTVuvula were avoided through the application of TORT in this salvage reirradiation setting. The patient successfully finished salvage SBRT with TORT resulting in no dysphagia or mucositis and maintained complete response at 12 months after treatment.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Kil WJ, Eisaman S, Wilke C, et al. Pharyngeal Constrictor-Sparing Salvage Stereotactic Body Radiation Therapy With Tongue-Out for In-Field Recurrence After Definitive Radiation Therapy for Head and Neck Cancer: Guide to Tongue-Out Radiation Therapy. Pract Radiat Oncol. 2024. PMID: 39047905. doi:10.1016/j.prro.2024.06.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。